Therapeutic psychedelics according to Johns Hopkins

A Johns Hopkins Neuroscientist on Psychedelics and Mental HealthПодробнее

Johns Hopkins Psychiatry Rounds | Psilocybin Research for Substance Use DisordersПодробнее

Johns Hopkins Psychiatry Grand Rounds | Nicola Cascella, M.D.Подробнее

The Johns Hopkins Briefing: Prescription Drug ShortagesПодробнее

Myositis Research Webinar with Dr. Julie Paik, MD, MHS-Johns Hopkins University School of Medicine.Подробнее

The Johns Hopkins Congressional Briefing: What’s Next for PsychedelicsПодробнее

Diet Therapy for Adults and Children with EpilepsyПодробнее

Johns Hopkins Psychiatry Grand Rounds | Psychedelic Treatment LandscapeПодробнее

The “heroic dose” of psychedelics, according to Johns Hopkins | Dr. Matthew JohnsonПодробнее

Johns Hopkins Psychedelic Research || Psilocybin Therapy || Ian GeithnerПодробнее

Johns Hopkins Medicine Receives First Federal Grant For Psychedelic Treatment Research In 50 yearsПодробнее

Psychedelic-Assisted Therapy with a Johns Hopkins ResearcherПодробнее

COVID-19 Update with Dr. Auwaerter of Johns Hopkins : Omicron Variant, Testing, and TreatmentПодробнее

Johns Hopkins Psychiatry Grand Rounds – Neuropsychopharmacology of Psychedelic DrugsПодробнее

An Evening With Hamilton Morris, hosted by the Johns Hopkins Psychedelic SocietyПодробнее

Session 2: Women's Mental Health Across the LifespanПодробнее

Treatment Options for Rheumatoid Arthritis | Johns Hopkins RheumatologyПодробнее

Johns Hopkins Study Shows Psilocybin Effective for a Year | Microdose Psychedelic InsightsПодробнее

Psychedelic Assisted Therapy - Immersive Sound Experience - 001Подробнее